SURF — Surface Oncology Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $65.08m
- $8.82m
- $30.00m
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing
Brief: Surface Oncology Says Co Applied To Transfer Listing Of Common Stock From Nasdaq Global Market To Nasdaq Capital Market On June 28
U.S. RESEARCH ROUNDUP-Amazon.com, Fedex, Nike
U.S. RESEARCH ROUNDUP- Humana, Steel Dynamics, Zscaler
U.S. STOCKS ON THE MOVE-Squarespace, NaaS Technology, American International Group
U.S. STOCKS ON THE MOVE-Virgin Galactic Holdings, Hospital stocks, Dollar General
U.S. STOCKS ON THE MOVE-Novavax, Nvidia, Humana
Surface Oncology up on Coherus buyout deal
Brief: Coherus To Acquire Surface Oncology
Surface Oncology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Surface Oncology Reports Financial Results And Corporate Highlights For First Quarter 2023
Brief: Surface Oncology Presents New Preclinical Data On Srf114 At Aacr Annual Meeting 2023
Brief: Surface Oncology Inc Reports Quarterly Diluted Net Loss Per Share Of $0.35
Surface Oncology Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Surface Oncology Inc Says Co Received Notice Of Delisting From Nasdaq
Brief: Vaccinex Announces First Patient Dosed With Anti-Ccr8 Antibody Licensed To Surface Oncology